Genopathy
Gene-Disorder Association · Article
Gene
SLC18A2
Solute Carrier Family 18 Member A2
Manually curatedApproved treatment annotated
Association Review

In brief

The association between SLC18A2 (Solute Carrier Family 18 Member A2) and Parkinson'S Disease is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 13
Compounds 2
Trials 31of 83 via SLC18A2 compounds
Publications 13
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
SLC18A2

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Parkinson'S Disease

The disorder

7 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Interventions

Therapeutics

2 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
06
Human studies

Clinical trials

83 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
07
Literature

Reading

13 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
08
Provenance

References & sources

13 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access